Stock listing
BX Swiss:EVMN Evommune, Inc. Aktie
Swiss listing (BX Swiss) of Evommune, Inc. · home listing NYSE:EVMN
Follow Evommune, Inc. into a list and get an email when it puts out news.
Home listing price · NYSE:EVMN
$6.73 USD -0.08 (-1.2%)
Close on Oct 30, 2026 · This listing has no price on 6ix; the price shown is the home listing's, NYSE:EVMN
- Day range
- $6.29 – $6.84 USDOct 30, 2026
- Volume
- 586,144 sharesOct 30, 2026
- Market cap
- $244.2M USDAt the close on Oct 30, 2026 · price × 36.29M shares outstanding
- 52-week range
- $4.94 – $33.20 USDLowest and highest trades, Nov 6, 2025 – Oct 30, 2026
- Traded on an average day
- $7.01M USDMedian day 570,350 shares · last 3 months, Jul 30, 2026 – Oct 30, 2026
Prices by listing
| Listing | Last | Change | Volume | Open | High | Low | Previous close | Price from |
|---|---|---|---|---|---|---|---|---|
| NYSE:EVMN · Home | $6.73 USD | -0.08 (-1.2%) | 586,144 | $6.65 | $6.84 | $6.29 | $6.81 | Close on Oct 30, 2026 |
Daily closes
Last 3 months, Jul 30, 2026 – Oct 30, 2026 · NYSE:EVMN · USD, adjusted for splits
| Day | Close | Change | % | Open | High | Low | Volume |
|---|---|---|---|---|---|---|---|
| $6.73 | -0.08 | -1.2% | $6.65 | $6.84 | $6.29 | 586,144 | |
| $6.81 | +0.50 | +7.9% | $6.38 | $7.174 | $6.28 | 1,154,441 | |
| $6.31 | +1.15 | +22.3% | $5.50 | $7.21 | $5.35 | 6,509,437 | |
| $5.16 | +0.03 | +0.6% | $5.13 | $5.26 | $4.96 | 1,301,850 | |
| $5.13 | +0.03 | +0.6% | $5.10 | $5.31 | $5.02 | 322,214 | |
| $5.10 | -0.11 | -2.1% | $5.18 | $5.18 | $4.94 | 280,527 | |
| $5.21 | +0.04 | +0.8% | $5.13 | $5.365 | $5.095 | 255,756 | |
| $5.17 | -0.21 | -3.9% | $5.41 | $5.521 | $5.125 | 383,385 | |
| $5.38 | +0.11 | +2.1% | $5.33 | $5.70 | $5.33 | 382,462 | |
| $5.27 | +0.10 | +1.9% | $5.30 | $5.43 | $5.125 | 422,783 | |
| $5.17 | -0.76 | -12.8% | $5.97 | $6.00 | $5.09 | 986,400 | |
| $5.93 | +0.16 | +2.8% | $5.90 | $6.00 | $5.81 | 579,100 | |
| $5.77 | -0.11 | -1.9% | $5.79 | $5.96 | $5.64 | 574,800 | |
| $5.88 | -0.17 | -2.8% | $6.05 | $6.05 | $5.85 | 804,900 | |
| $6.05 | -0.20 | -3.2% | $6.09 | $6.22 | $6.04 | 384,000 | |
| $6.25 | -0.16 | -2.5% | $6.40 | $6.44 | $6.175 | 558,000 | |
| $6.41 | +0.19 | +3.1% | $6.18 | $6.44 | $6.02 | 692,000 | |
| $6.22 | -0.39 | -5.9% | $6.51 | $6.525 | $6.15 | 2,112,500 | |
| $6.61 | -0.04 | -0.6% | $6.67 | $6.67 | $6.08 | 1,007,400 | |
| $6.65 | -0.27 | -3.9% | $6.86 | $7.216 | $6.52 | 1,365,200 | |
| $6.92 | -0.29 | -4.0% | $7.25 | $7.28 | $6.74 | 1,745,400 | |
| $7.21 | -1.05 | -12.7% | $8.25 | $8.30 | $6.99 | 1,524,900 | |
| $8.26 | -0.09 | -1.1% | $8.40 | $8.525 | $8.11 | 720,200 | |
| $8.35 | -0.04 | -0.5% | $8.36 | $8.65 | $8.11 | 807,600 | |
| $8.39 | -0.10 | -1.2% | $8.40 | $8.435 | $8.12 | 660,800 | |
| $8.49 | -0.31 | -3.5% | $8.78 | $8.78 | $8.33 | 541,100 | |
| $8.80 | +0.03 | +0.3% | $8.73 | $8.90 | $8.25 | 992,200 | |
| $8.77 | -0.83 | -8.6% | $9.48 | $9.54 | $8.69 | 872,400 | |
| $9.60 | +0.15 | +1.6% | $9.45 | $9.865 | $9.392 | 573,800 | |
| $9.45 | -0.20 | -2.1% | $9.70 | $9.70 | $9.35 | 603,000 | |
| $9.65 | +0.28 | +3.0% | $9.39 | $9.75 | $9.20 | 1,494,000 | |
| $9.37 | 0.00 | 0.0% | $9.57 | $9.67 | $9.35 | 405,805 | |
| $9.37 | -0.62 | -6.2% | $9.98 | $9.99 | $9.301 | 568,800 | |
| $9.99 | -0.44 | -4.2% | $10.43 | $10.43 | $9.80 | 520,000 | |
| $10.43 | -0.11 | -1.0% | $10.49 | $10.63 | $10.31 | 350,200 | |
| $10.54 | -0.02 | -0.2% | $10.66 | $10.82 | $10.50 | 388,900 | |
| $10.56 | -0.28 | -2.6% | $10.50 | $11.03 | $10.31 | 692,400 | |
| $10.84 | -2.24 | -17.1% | $11.90 | $12.10 | $10.30 | 3,986,300 | |
| $13.08 | +0.81 | +6.6% | $12.11 | $13.35 | $12.01 | 1,235,800 | |
| $12.27 | +0.27 | +2.2% | $11.87 | $12.46 | $11.87 | 249,100 | |
| $12.00 | -0.48 | -3.8% | $12.70 | $12.70 | $11.70 | 594,200 | |
| $12.48 | 0.00 | 0.0% | $12.50 | $12.80 | $12.33 | 366,100 | |
| $12.48 | -0.18 | -1.4% | $12.50 | $12.74 | $12.42 | 278,500 | |
| $12.66 | -0.57 | -4.3% | $13.08 | $13.13 | $12.61 | 571,900 | |
| $13.23 | -0.25 | -1.9% | $13.48 | $13.65 | $12.97 | 350,600 | |
| $13.48 | -0.63 | -4.5% | $14.13 | $14.18 | $13.41 | 252,500 | |
| $14.11 | +0.32 | +2.3% | $14.17 | $14.28 | $13.59 | 342,100 | |
| $13.79 | +0.12 | +0.9% | $13.79 | $14.44 | $13.60 | 340,400 | |
| $13.67 | -0.35 | -2.5% | $13.91 | $13.91 | $13.03 | 228,600 | |
| $14.02 | +0.45 | +3.3% | $13.74 | $14.25 | $13.70 | 326,500 | |
| $13.57 | -1.44 | -9.6% | $14.76 | $14.76 | $13.20 | 764,800 | |
| $15.01 | +0.79 | +5.6% | $14.57 | $15.06 | $14.48 | 293,200 | |
| $14.22 | -0.03 | -0.2% | $14.09 | $14.53 | $14.07 | 322,426 | |
| $14.25 | -0.40 | -2.7% | $14.61 | $14.84 | $14.20 | 333,169 | |
| $14.65 | +0.58 | +4.1% | $13.94 | $14.68 | $13.94 | 362,600 | |
| $14.07 | -0.05 | -0.4% | $14.14 | $14.59 | $14.06 | 345,200 | |
| $14.12 | -0.09 | -0.6% | $14.11 | $14.49 | $13.91 | 694,600 | |
| $14.21 | +0.14 | +1.0% | $14.26 | $14.62 | $13.63 | 380,269 | |
| $14.07 | -0.01 | -0.1% | $13.95 | $14.30 | $13.59 | 242,756 | |
| $14.08 | +0.70 | +5.2% | $13.70 | $14.36 | $13.70 | 374,000 | |
| $13.38 | +0.36 | +2.8% | $12.99 | $13.55 | $12.88 | 941,400 | |
| $13.02 | -0.09 | -0.7% | $12.98 | $13.40 | $12.79 | 637,800 | |
| $13.11 | +1.52 | +13.1% | $11.68 | $13.14 | $11.64 | 878,600 | |
| $11.59 | +0.34 | +3.0% | $11.14 | $11.67 | $10.90 | 862,600 | |
| $11.25 | -0.10 | -0.9% | $11.34 | $11.37 | $10.80 | 303,000 | |
| $11.35 | +0.30 | +2.7% | $10.81 | $11.39 | $10.81 | 437,500 |
- Ticker
- BX Swiss:EVMN
- Asset type
- Stock
- Sector
- Health care
- Industry
- Biotechnology
- Exchange
- BX Swiss
- Currency
- CHF
What changed lately
Latest news release · Oct 1, 2026
Evommune Presents Late-Breaking Phase 2a Proof-of-Concept Data Evaluating EVO301 in Atopic Dermatitis at European Academy of Dermatology and Venereology Congress
Latest deck · October 2026
Investor Presentation (October 2026)
Investor deck · 47 slides
Latest news
Evommune Presents Late-Breaking Phase 2a Proof-of-Concept Data Evaluating EVO301 in Atopic Dermatitis at European Academy of Dermatology and Venereology Congress
Oct 1, 2026
Closed $7.21 (-12.7%) on Oct 1, 2026
Evommune Announces Late-Breaker Presentation of Phase 2a Data for EVO301 in Atopic Dermatitis at European Academy of Dermatology & Venereology 2026 Congress
Sep 23, 2026
Closed $8.80 (+0.3%) on Sep 24, 2026
Evommune Announces Top-line Results from EVO756 Phase 2b Trial in Moderate-to-Severe Atopic Dermatitis
Sep 8, 2026
Closed $10.84 (-17.1%) on Sep 9, 2026
Evommune Reports Second Quarter 2026 Financial Results and Provides Business Highlights
Aug 6, 2026
Closed $14.08 (+5.2%) on Aug 7, 2026
Evommune Initiates Phase 2b Clinical Trial of MRGPRX2 Inhibitor EVO756 in Migraine Prophylaxis
Jul 30, 2026
Closed $11.35 (+2.7%) on Jul 30, 2026
Evommune Announces Top-line Results from EVO756 Phase 2b Trial in Moderate-to-Severe Chronic Spontaneous Urticaria
Jun 29, 2026
Closed $15.05 (-40.2%) on Jun 29, 2026
Evommune Reports First Quarter 2026 Financial Results and Provides Business Highlights
May 7, 2026
Closed $22.92 (+1.9%) on May 8, 2026
Evommune to Host KOL Webinar on April 13, 2026 Highlighting the Potential of MRGPRX2 Inhibition in Migraine
Apr 6, 2026
Closed $24.58 (+3.6%) on Apr 6, 2026
Evommune Reports Fourth Quarter and Full Year 2025 Financial Results and Provides Business Highlights
Mar 5, 2026
Closed $26.50 (+5.6%) on Mar 6, 2026
Evommune Announces $125 Million Private Placement
Feb 12, 2026
Closed $31.57 (+13.2%) on Feb 13, 2026
Decks
Investor Presentation (October 2026)
Investor deck · 47 slides · October 2026
European Academy of Dermatology and Venereology Annual Meeting 2026
Conference · 10 slides · Oct 1, 2026
Investor Presentation (September 2026)
Investor deck · 39 slides · Sep 15, 2026
Investor Presentation (September 2026)
Investor deck · 42 slides · September 2026
Evommune, Inc. on 6ix
- Sector
- Health care
- Industry
- Biotechnology
- News releases
- 13 in the last 12 months · 14 in all · newest Oct 1, 2026 · oldest 2025
- Decks
- 10 decks · latest October 2026
Where Evommune, Inc. is listed
| Listing | Exchange | Country | Currency |
|---|---|---|---|
| NYSE:EVMN · Home listing | NYSE | United States | USD |
| BX Swiss:EVMN · This page | BX Swiss | Switzerland | CHF |
| BOATS:EVMN | BOATS | United States | USD |
| BX Swiss:EVMNUSD | BX Swiss | Switzerland | USD |
Log in to ask 6ix AI your own questions about Evommune, Inc.